Results 111 to 120 of about 6,415 (210)

Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria

Journal of Clinical Microbiology
This study addresses the use of other echinocandins as surrogate markers to predict the susceptibility of rezafungin against the six most common Candida spp.
Marisa L. Winkler, Lalitagauri Deshpande, John H. Kimbrough, Maura Karr, Paul Rhomberg, Abby L. Klauer, Mariana Castanheira   +6 more
doaj   +1 more source

Clinical experience of Anidulafungin for the treatment of patients with documented Candidemia

, 2010
Candida species are the most common causes of invasive fungal infections in humans, producing infections that range from mucocutaneous disorders to invasive disease that can involve any organ.
Ghezzi M. C., Raponi G., Toma L., Venditti M., de Rosa F. G., Falcone M., Pasero D., Russo A.   +7 more
core   +1 more source

DP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM

Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.
A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi   +19 more
doaj  

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source

Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025. [PDF]

Emerg Infect Dis
Foo TJ, Koh MCY, Chew KL, Juay L, Wu SJ.
europepmc   +1 more source

Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in <i>Candida auris</i> (<i>Candidozyma auris</i>) Isolates. [PDF]

Infect Drug Resist
Turan D, Sarmis A, Adaleti R, Aksaray S.
europepmc   +1 more source

A Calcineurin Inhibitor as an Enhancer of <i>Candida</i> Susceptibility to Anidulafungin. [PDF]

ACS Omega
Rovira I, Montemayor E, Gil-Alonso S, Miranda-Cadena K, Sanchez-Reus F, Quindós G, Eraso E, Jauregizar N.   +7 more
europepmc   +1 more source

Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance. [PDF]

Front Cell Infect Microbiol
Steixner S, Vahedi-Shahandashti R, Eisele D, Ruppitsch W, Lass-Flörl C.   +4 more
europepmc   +1 more source

Antifungal susceptibility profiles of candidemia isolates on the east coast of Peninsular Malaysia and reliability of Etest compared to Sensititre YeastOne. [PDF]

Microbiol Spectr
Abdullah SNS, Tzar MN, Othman SN.
europepmc   +1 more source

Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae. [PDF]

Genetics
Durand R, Torbey AG, Giguere M, Pageau A, Dubé AK, Lagüe P, Landry CR.   +6 more
europepmc   +1 more source